JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,688,000 | -22.8% | 1,148,780 | 0.0% | 1.17% | -17.6% |
| Q2 2022 | $3,481,000 | -55.4% | 1,148,780 | 0.0% | 1.42% | -32.7% |
| Q1 2022 | $7,800,000 | -18.7% | 1,148,780 | 0.0% | 2.12% | -11.8% |
| Q4 2021 | $9,592,000 | -57.7% | 1,148,780 | -62.3% | 2.40% | -44.2% |
| Q3 2021 | $22,652,000 | +9.3% | 3,048,780 | 0.0% | 4.30% | +18.8% |
| Q2 2021 | $20,732,000 | -33.8% | 3,048,780 | 0.0% | 3.62% | -8.6% |
| Q1 2021 | $31,311,000 | +46.7% | 3,048,780 | 0.0% | 3.96% | +116.1% |
| Q4 2020 | $21,342,000 | -14.2% | 3,048,780 | 0.0% | 1.83% | -12.3% |
| Q3 2020 | $24,878,000 | +18.3% | 3,048,780 | 0.0% | 2.09% | -31.9% |
| Q2 2020 | $21,037,000 | +45.3% | 3,048,780 | 0.0% | 3.07% | -22.1% |
| Q1 2020 | $14,482,000 | -45.6% | 3,048,780 | 0.0% | 3.94% | -66.5% |
| Q4 2019 | $26,616,000 | +162.2% | 3,048,780 | 0.0% | 11.75% | +104.3% |
| Q3 2019 | $10,152,000 | -32.7% | 3,048,780 | 0.0% | 5.75% | -10.3% |
| Q2 2019 | $15,091,000 | -20.2% | 3,048,780 | 0.0% | 6.42% | -30.7% |
| Q1 2019 | $18,902,000 | +84.0% | 3,048,780 | 0.0% | 9.26% | +7.6% |
| Q4 2018 | $10,274,000 | -48.2% | 3,048,780 | 0.0% | 8.61% | -2.7% |
| Q3 2018 | $19,817,000 | -15.1% | 3,048,780 | 0.0% | 8.85% | +13.8% |
| Q2 2018 | $23,354,000 | -65.7% | 3,048,780 | 0.0% | 7.78% | -68.3% |
| Q1 2018 | $68,140,000 | +75.3% | 3,048,780 | 0.0% | 24.53% | +80.2% |
| Q4 2017 | $38,872,000 | – | 3,048,780 | – | 13.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
| TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
| Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
| Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
| Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
| PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
| Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
| Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |